These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 15509792)
1. The Wt1+/R394W mouse displays glomerulosclerosis and early-onset renal failure characteristic of human Denys-Drash syndrome. Gao F; Maiti S; Sun G; Ordonez NG; Udtha M; Deng JM; Behringer RR; Huff V Mol Cell Biol; 2004 Nov; 24(22):9899-910. PubMed ID: 15509792 [TBL] [Abstract][Full Text] [Related]
2. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1. Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912 [TBL] [Abstract][Full Text] [Related]
3. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis. Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483 [TBL] [Abstract][Full Text] [Related]
4. [Clinical and pathological features of Denys-Drash syndrome: report of 3 cases]. Wang HY; Sun LZ; Yue ZH; Yang J; Jiang XY; Mo Y Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):855-8. PubMed ID: 23302619 [TBL] [Abstract][Full Text] [Related]
5. Denys-Drash syndrome with neonatal renal failure in monozygotic twins due to c.1097G>A mutation in the WT1 gene. Furtado LV; Pysher T; Opitz J; Lamb R; Comstock J; Batish S; Mauch T; Nelson R; Zhou H Fetal Pediatr Pathol; 2011; 30(4):266-72. PubMed ID: 21434831 [TBL] [Abstract][Full Text] [Related]
6. A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X. Heathcott RW; Morison IM; Gubler MC; Corbett R; Reeve AE Hum Mutat; 2002 Apr; 19(4):462. PubMed ID: 11933209 [TBL] [Abstract][Full Text] [Related]
7. A novel WT1 gene mutation in a three-generation family with progressive isolated focal segmental glomerulosclerosis. Benetti E; Caridi G; Malaventura C; Dagnino M; Leonardi E; Artifoni L; Ghiggeri GM; Tosatto SC; Murer L Clin J Am Soc Nephrol; 2010 Apr; 5(4):698-702. PubMed ID: 20150449 [TBL] [Abstract][Full Text] [Related]
8. Bigenic heterozygosity and the development of steroid-resistant focal segmental glomerulosclerosis. Löwik M; Levtchenko E; Westra D; Groenen P; Steenbergen E; Weening J; Lilien M; Monnens L; van den Heuvel L Nephrol Dial Transplant; 2008 Oct; 23(10):3146-51. PubMed ID: 18443213 [TBL] [Abstract][Full Text] [Related]
10. Focal Segmental Membranoproliferative Glomerulonephritis: A Histological Variant of Denys-Drash Syndrome. Karmila AB; Yap YC; Appadurai M; Oh L; Fazarina M; Abd Ghani F; Ariffin H Fetal Pediatr Pathol; 2021 Apr; 40(2):113-120. PubMed ID: 31707902 [No Abstract] [Full Text] [Related]
11. WT1 intron 9 splice acceptor site mutation in a 46,XY male with focal segmental glomerulosclerosis. Kanemoto K; Ishikura K; Ariyasu D; Hamasaki Y; Hataya H; Hasegawa Y; Ikeda M Pediatr Nephrol; 2007 Mar; 22(3):454-8. PubMed ID: 17061122 [TBL] [Abstract][Full Text] [Related]
12. Effects on kidney disease, fertility and development in mice inheriting a protein-truncating Denys-Drash syndrome allele (Wt1tmT396). Patek CE; Brownstein DG; Fleming S; Wroe C; Rose L; Webb A; Berry RL; Devenney PS; Walker M; Maddocks OD; Lawrence NJ; Harrison DJ; Wood KM; Miles CG; Hooper ML Transgenic Res; 2008 Jun; 17(3):459-75. PubMed ID: 18040647 [TBL] [Abstract][Full Text] [Related]
13. A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys-Drash syndrome. da Silva TE; Nishi MY; Costa EM; Martin RM; Carvalho FM; Mendonca BB; Domenice S Pediatr Nephrol; 2011 Aug; 26(8):1311-5. PubMed ID: 21559934 [TBL] [Abstract][Full Text] [Related]
14. Prophylactic bilateral nephrectomy and preemptive kidney transplantation for Denys-Drash syndrome prior to development of kidney failure. Hosokawa C; Hotta K; Okamoto T; Cho Y; Hirose T; Iwahara N; Manabe A; Shinohara N Pediatr Nephrol; 2024 Mar; 39(3):905-909. PubMed ID: 37572117 [TBL] [Abstract][Full Text] [Related]
15. Retrospective mutational analysis of NPHS1, NPHS2, WT1 and LAMB2 in children with steroid-resistant focal segmental glomerulosclerosis - a single-centre experience. Bińczak-Kuleta A; Rubik J; Litwin M; Ryder M; Lewandowska K; Taryma-Leśniak O; Clark JS; Grenda R; Ciechanowicz A Bosn J Basic Med Sci; 2014 May; 14(2):89-93. PubMed ID: 24856380 [TBL] [Abstract][Full Text] [Related]
16. Integration of Cistromic and Transcriptomic Analyses Identifies Nphs2, Mafb, and Magi2 as Wilms' Tumor 1 Target Genes in Podocyte Differentiation and Maintenance. Dong L; Pietsch S; Tan Z; Perner B; Sierig R; Kruspe D; Groth M; Witzgall R; Gröne HJ; Platzer M; Englert C J Am Soc Nephrol; 2015 Sep; 26(9):2118-28. PubMed ID: 25556170 [TBL] [Abstract][Full Text] [Related]
17. A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development. Natoli TA; Liu J; Eremina V; Hodgens K; Li C; Hamano Y; Mundel P; Kalluri R; Miner JH; Quaggin SE; Kreidberg JA J Am Soc Nephrol; 2002 Aug; 13(8):2058-67. PubMed ID: 12138137 [TBL] [Abstract][Full Text] [Related]
18. [Clinical and pathological features and mutational types of WT1 mutation-associated nephropathy]. Sun LZ; Wang HY; Li M; Lin HR; Wu JL; Tang W; Li YJ; Yue ZH; Liu T; Chen HM; Hu MY Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):769-774. PubMed ID: 30293282 [No Abstract] [Full Text] [Related]
19. A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome. Little S; Hanks S; King-Underwood L; Picton S; Cullinane C; Rapley E; Rahman N; Pritchard-Jones K Pediatr Nephrol; 2005 Jan; 20(1):81-5. PubMed ID: 15503171 [TBL] [Abstract][Full Text] [Related]